{"pmid":32271373,"title":"Predictors of refractory Coronavirus disease (COVID-19) pneumonia.","text":["Predictors of refractory Coronavirus disease (COVID-19) pneumonia.","Clin Infect Dis","Abu-Raya, Bahaa","32271373"],"journal":"Clin Infect Dis","authors":["Abu-Raya, Bahaa"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32271373","week":"202015|Apr 06 - Apr 12","doi":"10.1093/cid/ciaa409","source":"PubMed","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1663620082988744704,"score":7.9164424,"similar":[{"pmid":32173725,"title":"Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China.","text":["Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China.","BACKGROUND: Since December 2019, novel coronavirus (SARS-CoV-2)-infected pneumonia (COVID-19) occurred in Wuhan, and rapidly spread throughout China. This study aimed to clarify the characteristics of patients with refractory COVID-19. METHODS: In this retrospective single-center study, we included 155 consecutive patients with confirmed COVID-19 in Zhongnan Hospital of Wuhan University from January 1st to February 5th. The cases were divided into general and refractory COVID-19 groups according to the clinical efficacy after hospitalization, and the difference between groups were compared. RESULTS: Compared with general COVID-19 patients (45.2%), refractory patients had an older age, male sex, more underlying comorbidities, lower incidence of fever, higher levels of maximum temperature among fever cases, higher incidence of breath shortness and anorexia, severer disease assessment on admission, high levels of neutrophil, aspartate aminotransferase (AST), lactate dehydrogenase (LDH) and C-reactive protein, lower levels of platelets and albumin, and higher incidence of bilateral pneumonia and pleural effusion (P<0.05). Refractory COVID-19 patients were more likely to receive oxygen, mechanical ventilation, expectorant, and adjunctive treatment including corticosteroid, antiviral drugs and immune enhancer (P<0.05). After adjustment, those with refractory COVID-19 were also more likely to have a male sex and manifestations of anorexia and fever on admission, and receive oxygen, expectorant and adjunctive agents (P<0.05) when considering the factors of disease severity on admission, mechanical ventilation, and ICU transfer. CONCLUSION: Nearly 50% COVID-19 patients could not reach obvious clinical and radiological remission within 10 days after hospitalization. The patients with male sex, anorexia and no fever on admission predicted poor efficacy.","Clin Infect Dis","Mo, Pingzheng","Xing, Yuanyuan","Xiao, Yu","Deng, Liping","Zhao, Qiu","Wang, Hongling","Xiong, Yong","Cheng, Zhenshun","Gao, Shicheng","Liang, Ke","Luo, Mingqi","Chen, Tielong","Song, Shihui","Ma, Zhiyong","Chen, Xiaoping","Zheng, Ruiying","Cao, Qian","Wang, Fan","Zhang, Yongxi","32173725"],"abstract":["BACKGROUND: Since December 2019, novel coronavirus (SARS-CoV-2)-infected pneumonia (COVID-19) occurred in Wuhan, and rapidly spread throughout China. This study aimed to clarify the characteristics of patients with refractory COVID-19. METHODS: In this retrospective single-center study, we included 155 consecutive patients with confirmed COVID-19 in Zhongnan Hospital of Wuhan University from January 1st to February 5th. The cases were divided into general and refractory COVID-19 groups according to the clinical efficacy after hospitalization, and the difference between groups were compared. RESULTS: Compared with general COVID-19 patients (45.2%), refractory patients had an older age, male sex, more underlying comorbidities, lower incidence of fever, higher levels of maximum temperature among fever cases, higher incidence of breath shortness and anorexia, severer disease assessment on admission, high levels of neutrophil, aspartate aminotransferase (AST), lactate dehydrogenase (LDH) and C-reactive protein, lower levels of platelets and albumin, and higher incidence of bilateral pneumonia and pleural effusion (P<0.05). Refractory COVID-19 patients were more likely to receive oxygen, mechanical ventilation, expectorant, and adjunctive treatment including corticosteroid, antiviral drugs and immune enhancer (P<0.05). After adjustment, those with refractory COVID-19 were also more likely to have a male sex and manifestations of anorexia and fever on admission, and receive oxygen, expectorant and adjunctive agents (P<0.05) when considering the factors of disease severity on admission, mechanical ventilation, and ICU transfer. CONCLUSION: Nearly 50% COVID-19 patients could not reach obvious clinical and radiological remission within 10 days after hospitalization. The patients with male sex, anorexia and no fever on admission predicted poor efficacy."],"journal":"Clin Infect Dis","authors":["Mo, Pingzheng","Xing, Yuanyuan","Xiao, Yu","Deng, Liping","Zhao, Qiu","Wang, Hongling","Xiong, Yong","Cheng, Zhenshun","Gao, Shicheng","Liang, Ke","Luo, Mingqi","Chen, Tielong","Song, Shihui","Ma, Zhiyong","Chen, Xiaoping","Zheng, Ruiying","Cao, Qian","Wang, Fan","Zhang, Yongxi"],"date":"2020-03-17T11:00:00Z","year":2020,"_id":"32173725","week":"202012|Mar 16 - Mar 22","doi":"10.1093/cid/ciaa270","keywords":["COVID-19","SARS-CoV-2","clinical efficacy","predictors"],"source":"PubMed","locations":["neutrophil","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1663352133911576577,"score":78.34374},{"pmid":32211755,"title":"Epidemiological and Clinical Predictors of COVID-19.","text":["Epidemiological and Clinical Predictors of COVID-19.","BACKGROUND: Rapid identification of COVID-19 cases, which is crucial to outbreak containment efforts, is challenging due to the lack of pathognomonic symptoms and in settings with limited capacity for specialized nucleic acid-based reverse transcription polymerase chain reaction (PCR) testing. METHODS: This retrospective case-control study involves subjects (7 to 98 years) presenting at the designated national outbreak screening centre and tertiary care hospital in Singapore for SARS-CoV-2 testing from January 26 to February 16, 2020. COVID-19 status was confirmed by PCR testing of sputum, nasopharyngeal swabs or throat swabs. Demographic, clinical, laboratory and exposure-risk variables ascertainable at presentation were analyzed to develop an algorithm for estimating the risk of COVID-19. Model development used Akaike's information criterion in a stepwise fashion to build logistic regression models, which were then translated into prediction scores. Performance was measured using receiver operating characteristics curves, adjusting for over-confidence using leave-out-one cross validation. RESULTS: The study population included 788 subjects, of whom 54 (6.9%) were SARS-CoV-2 positive and 734 (93.1%) were SARS-CoV-2 negative. The median age was 34 years and 407 (51.7%) were female. Using leave-out-one cross validation, all the models incorporating clinical tests (Models 1, 2 and 3) performed well with areas under the receiver operating characteristics curve (AUC) of 0.91, 0.88 and 0.88 respectively. In comparison, Model 4 had an AUC of 0.65. CONCLUSIONS: Rapidly ascertainable clinical and laboratory data could identify individuals at high risk of COVID-19 and enable prioritization of PCR-testing and containment efforts. Basic laboratory test results were crucial to prediction models.","Clin Infect Dis","Sun, Yinxiaohe","Koh, Vanessa","Marimuthu, Kalisvar","Ng, Oon Tek","Young, Barnaby","Vasoo, Shawn","Chan, Monica","Lee, Vernon J M","De, Partha P","Barkham, Timothy","Lin, Raymond T P","Cook, Alex R","Leo, Yee Sin","32211755"],"abstract":["BACKGROUND: Rapid identification of COVID-19 cases, which is crucial to outbreak containment efforts, is challenging due to the lack of pathognomonic symptoms and in settings with limited capacity for specialized nucleic acid-based reverse transcription polymerase chain reaction (PCR) testing. METHODS: This retrospective case-control study involves subjects (7 to 98 years) presenting at the designated national outbreak screening centre and tertiary care hospital in Singapore for SARS-CoV-2 testing from January 26 to February 16, 2020. COVID-19 status was confirmed by PCR testing of sputum, nasopharyngeal swabs or throat swabs. Demographic, clinical, laboratory and exposure-risk variables ascertainable at presentation were analyzed to develop an algorithm for estimating the risk of COVID-19. Model development used Akaike's information criterion in a stepwise fashion to build logistic regression models, which were then translated into prediction scores. Performance was measured using receiver operating characteristics curves, adjusting for over-confidence using leave-out-one cross validation. RESULTS: The study population included 788 subjects, of whom 54 (6.9%) were SARS-CoV-2 positive and 734 (93.1%) were SARS-CoV-2 negative. The median age was 34 years and 407 (51.7%) were female. Using leave-out-one cross validation, all the models incorporating clinical tests (Models 1, 2 and 3) performed well with areas under the receiver operating characteristics curve (AUC) of 0.91, 0.88 and 0.88 respectively. In comparison, Model 4 had an AUC of 0.65. CONCLUSIONS: Rapidly ascertainable clinical and laboratory data could identify individuals at high risk of COVID-19 and enable prioritization of PCR-testing and containment efforts. Basic laboratory test results were crucial to prediction models."],"journal":"Clin Infect Dis","authors":["Sun, Yinxiaohe","Koh, Vanessa","Marimuthu, Kalisvar","Ng, Oon Tek","Young, Barnaby","Vasoo, Shawn","Chan, Monica","Lee, Vernon J M","De, Partha P","Barkham, Timothy","Lin, Raymond T P","Cook, Alex R","Leo, Yee Sin"],"date":"2020-03-27T11:00:00Z","year":2020,"_id":"32211755","week":"202013|Mar 23 - Mar 29","doi":"10.1093/cid/ciaa322","keywords":["COVID-19","Prediction model","Risk factors","SARS-CoV-2"],"source":"PubMed","locations":["Singapore"],"countries":["Singapore"],"countries_codes":["SGP|Singapore"],"topics":["Diagnosis"],"weight":1,"_version_":1663352134921355264,"score":52.629116},{"pmid":32268300,"title":"Biomarkers of biological age as predictors of COVID-19 disease severity.","text":["Biomarkers of biological age as predictors of COVID-19 disease severity.","Aging (Albany NY)","Lauc, Gordan","Sinclair, David","32268300"],"journal":"Aging (Albany NY)","authors":["Lauc, Gordan","Sinclair, David"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32268300","week":"202015|Apr 06 - Apr 12","doi":"10.18632/aging.103052","keywords":["COVID-19","biological age","biomarkers of biological age"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1663609715792281601,"score":50.65526},{"pmid":32269088,"title":"Predictors of Mortality for Patients with COVID-19 Pneumonia Caused by SARS-CoV-2: A Prospective Cohort Study.","text":["Predictors of Mortality for Patients with COVID-19 Pneumonia Caused by SARS-CoV-2: A Prospective Cohort Study.","To identify factors associated with the death for patients with COVID-19 pneumonia caused by a novel coronavirus SARS-CoV-2.All clinical and laboratory parameters were collected prospectively from a cohort of patients with COVID-19 pneumonia who were hospitalised to Wuhan Pulmonary Hospital, Wuhan City, Hubei Province, China, between December 25, 2019 and February 7, 2020. Univariate and multivariate logistic regression was performed to investigate the relationship between each variable and the risk for death of COVID-19 pneumonia patients.A total of 179 patients with COVID-19 pneumonia (97 male and 82 female) were included in the present prospective study, of whom 21 died. Univariate and multivariate logistic regression analysis revealed that age >/=65 years (odd ratio, 3.765; 95% confidence interval, 1.14617.394; p=0.023), preexisting concurrent cardiovascular or cerebrovascular diseases (2.464; 0.7558.044; p=0.007), CD3(+)CD8(+) T cells </=75 cell.muL(-1) (3.982; 1.13214.006; p<0.001), and cardiac troponin I>/=0.05 ng.mL(-1) (4.077; 1.16614.253; p<0.001) were associated with an increase in risk of mortality of COVID-19 pneumonia. In the sex, age, and comorbid illness-matched case study, CD3(+)CD8(+) T cells </=75 cell.muL(-1) and cardiac troponin I>/=0.05 ng.mL(-1) remained to be the predictors for high mortality of COVID-19 pneumonia.We identified four risk factors, age >/=65 years, preexisting concurrent cardiovascular or cerebrovascular diseases, CD3(+)CD8(+) T cells </=75 cell.muL(-1), and cardiac troponin I>/=0.05 ng.mL(-1), especially the latter two factors, were predictors for mortality of COVID-19 pneumonia patients.","Eur Respir J","Du, Rong-Hui","Liang, Li-Rong","Yang, Cheng-Qing","Wang, Wen","Cao, Tan-Ze","Li, Ming","Guo, Guang-Yun","Du, Juan","Zheng, Chun-Lan","Zhu, Qi","Hu, Ming","Li, Xu-Yan","Peng, Peng","Shi, Huan-Zhong","32269088"],"abstract":["To identify factors associated with the death for patients with COVID-19 pneumonia caused by a novel coronavirus SARS-CoV-2.All clinical and laboratory parameters were collected prospectively from a cohort of patients with COVID-19 pneumonia who were hospitalised to Wuhan Pulmonary Hospital, Wuhan City, Hubei Province, China, between December 25, 2019 and February 7, 2020. Univariate and multivariate logistic regression was performed to investigate the relationship between each variable and the risk for death of COVID-19 pneumonia patients.A total of 179 patients with COVID-19 pneumonia (97 male and 82 female) were included in the present prospective study, of whom 21 died. Univariate and multivariate logistic regression analysis revealed that age >/=65 years (odd ratio, 3.765; 95% confidence interval, 1.14617.394; p=0.023), preexisting concurrent cardiovascular or cerebrovascular diseases (2.464; 0.7558.044; p=0.007), CD3(+)CD8(+) T cells </=75 cell.muL(-1) (3.982; 1.13214.006; p<0.001), and cardiac troponin I>/=0.05 ng.mL(-1) (4.077; 1.16614.253; p<0.001) were associated with an increase in risk of mortality of COVID-19 pneumonia. In the sex, age, and comorbid illness-matched case study, CD3(+)CD8(+) T cells </=75 cell.muL(-1) and cardiac troponin I>/=0.05 ng.mL(-1) remained to be the predictors for high mortality of COVID-19 pneumonia.We identified four risk factors, age >/=65 years, preexisting concurrent cardiovascular or cerebrovascular diseases, CD3(+)CD8(+) T cells </=75 cell.muL(-1), and cardiac troponin I>/=0.05 ng.mL(-1), especially the latter two factors, were predictors for mortality of COVID-19 pneumonia patients."],"journal":"Eur Respir J","authors":["Du, Rong-Hui","Liang, Li-Rong","Yang, Cheng-Qing","Wang, Wen","Cao, Tan-Ze","Li, Ming","Guo, Guang-Yun","Du, Juan","Zheng, Chun-Lan","Zhu, Qi","Hu, Ming","Li, Xu-Yan","Peng, Peng","Shi, Huan-Zhong"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32269088","week":"202015|Apr 06 - Apr 12","doi":"10.1183/13993003.00524-2020","source":"PubMed","locations":["China","Wuhan","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1663620083072630786,"score":47.181686},{"pmid":32275643,"title":"Predictors for imaging progression on chest CT from coronavirus disease 2019 (COVID-19) patients.","text":["Predictors for imaging progression on chest CT from coronavirus disease 2019 (COVID-19) patients.","OBJECTIVE: This study aimed to investigate the potential parameters associated with imaging progression on chest CT from coronavirus disease 19 (COVID-19) patients. RESULTS: The average age of 273 COVID-19 patients enrolled with imaging progression were older than those without imaging progression (p = 0.006). The white blood cells, platelets, neutrophils and acid glycoprotein were all decreased in imaging progression patients (all p < 0.05), and monocytes were increased (p = 0.025). The parameters including homocysteine, urea, creatinine and serum cystatin C were significantly higher in imaging progression patients (all p < 0.05), while eGFR decreased (p < 0.001). Monocyte-lymphocyte ratio (MLR) was significantly higher in imaging progression patients compared to that in imaging progression-free ones (p < 0.001). Logistic models revealed that age, MLR, homocysteine and period from onset to admission were factors for predicting imaging progression on chest CT at first week from COVID-19 patients (all p < 0.05). CONCLUSION: Age, MLR, homocysteine and period from onset to admission could predict imaging progression on chest CT from COVID-19 patients. METHODS: The primary outcome was imaging progression on chest CT. Baseline parameters were collected at the first day of admission. Imaging manifestations on chest CT were followed-up at (6+/-1) days.","Aging (Albany NY)","Yang, Zongguo","Shi, Jia","He, Zhang","Lu, Ying","Xu, Qingnian","Ye, Chen","Chen, Shishi","Tang, Bozong","Yin, Keshan","Lu, Yunfei","Chen, Xiaorong","32275643"],"abstract":["OBJECTIVE: This study aimed to investigate the potential parameters associated with imaging progression on chest CT from coronavirus disease 19 (COVID-19) patients. RESULTS: The average age of 273 COVID-19 patients enrolled with imaging progression were older than those without imaging progression (p = 0.006). The white blood cells, platelets, neutrophils and acid glycoprotein were all decreased in imaging progression patients (all p < 0.05), and monocytes were increased (p = 0.025). The parameters including homocysteine, urea, creatinine and serum cystatin C were significantly higher in imaging progression patients (all p < 0.05), while eGFR decreased (p < 0.001). Monocyte-lymphocyte ratio (MLR) was significantly higher in imaging progression patients compared to that in imaging progression-free ones (p < 0.001). Logistic models revealed that age, MLR, homocysteine and period from onset to admission were factors for predicting imaging progression on chest CT at first week from COVID-19 patients (all p < 0.05). CONCLUSION: Age, MLR, homocysteine and period from onset to admission could predict imaging progression on chest CT from COVID-19 patients. METHODS: The primary outcome was imaging progression on chest CT. Baseline parameters were collected at the first day of admission. Imaging manifestations on chest CT were followed-up at (6+/-1) days."],"journal":"Aging (Albany NY)","authors":["Yang, Zongguo","Shi, Jia","He, Zhang","Lu, Ying","Xu, Qingnian","Ye, Chen","Chen, Shishi","Tang, Bozong","Yin, Keshan","Lu, Yunfei","Chen, Xiaorong"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32275643","week":"202015|Apr 06 - Apr 12","doi":"10.18632/aging.102999","keywords":["COVID-19","MLR","age","coronavirus disease 2019","monocyte-lymphocyte ratio"],"source":"PubMed","locations":["homocysteine","urea"],"topics":["Diagnosis"],"weight":1,"_version_":1663712077907230720,"score":46.90459}]}